IBDEI07N ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7565,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,7566,0)
 ;;=D69.59^^42^498^177
 ;;^UTILITY(U,$J,358.3,7566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7566,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,7566,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,7566,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,7567,0)
 ;;=C22.7^^42^498^44
 ;;^UTILITY(U,$J,358.3,7567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7567,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,7567,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,7567,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,7568,0)
 ;;=D75.89^^42^498^54
 ;;^UTILITY(U,$J,358.3,7568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7568,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,7568,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,7568,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,7569,0)
 ;;=D47.Z9^^42^498^169
 ;;^UTILITY(U,$J,358.3,7569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7569,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,7569,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,7569,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,7570,0)
 ;;=D05.82^^42^498^32
 ;;^UTILITY(U,$J,358.3,7570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7570,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,7570,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,7570,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,7571,0)
 ;;=D05.81^^42^498^34
 ;;^UTILITY(U,$J,358.3,7571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7571,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,7571,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,7571,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,7572,0)
 ;;=D05.80^^42^498^36
 ;;^UTILITY(U,$J,358.3,7572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7572,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,7572,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,7572,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,7573,0)
 ;;=D56.8^^42^498^182
 ;;^UTILITY(U,$J,358.3,7573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7573,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,7573,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,7573,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,7574,0)
 ;;=C82.89^^42^498^74
 ;;^UTILITY(U,$J,358.3,7574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7574,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,7574,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,7574,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,7575,0)
 ;;=D51.8^^42^498^189
 ;;^UTILITY(U,$J,358.3,7575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7575,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,7575,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,7575,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,7576,0)
 ;;=I80.9^^42^498^174
 ;;^UTILITY(U,$J,358.3,7576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7576,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,7576,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,7576,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,7577,0)
 ;;=D45.^^42^498^175
 ;;^UTILITY(U,$J,358.3,7577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7577,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,7577,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,7577,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,7578,0)
 ;;=C77.3^^42^498^107
 ;;^UTILITY(U,$J,358.3,7578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7578,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,7578,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,7578,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,7579,0)
 ;;=C77.2^^42^498^123
 ;;^UTILITY(U,$J,358.3,7579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7579,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,7579,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,7579,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,7580,0)
 ;;=C77.1^^42^498^124
 ;;^UTILITY(U,$J,358.3,7580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7580,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,7580,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,7580,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,7581,0)
 ;;=C77.0^^42^498^140
 ;;^UTILITY(U,$J,358.3,7581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7581,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,7581,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,7581,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,7582,0)
 ;;=C77.8^^42^498^141
 ;;^UTILITY(U,$J,358.3,7582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7582,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,7582,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,7582,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,7583,0)
 ;;=C79.51^^42^498^111
 ;;^UTILITY(U,$J,358.3,7583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7583,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,7583,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,7583,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,7584,0)
 ;;=C79.52^^42^498^110
 ;;^UTILITY(U,$J,358.3,7584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7584,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,7584,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,7584,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,7585,0)
 ;;=C79.31^^42^498^112
 ;;^UTILITY(U,$J,358.3,7585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7585,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,7585,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,7585,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,7586,0)
 ;;=C79.72^^42^498^127
 ;;^UTILITY(U,$J,358.3,7586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7586,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,7586,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,7586,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,7587,0)
 ;;=C78.02^^42^498^131
 ;;^UTILITY(U,$J,358.3,7587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7587,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,7587,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,7587,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,7588,0)
 ;;=C78.7^^42^498^136
 ;;^UTILITY(U,$J,358.3,7588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7588,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,7588,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,7588,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,7589,0)
 ;;=C79.71^^42^498^149
 ;;^UTILITY(U,$J,358.3,7589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7589,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,7589,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,7589,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,7590,0)
 ;;=C78.01^^42^498^153
 ;;^UTILITY(U,$J,358.3,7590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7590,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,7590,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,7590,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,7591,0)
 ;;=C79.70^^42^498^104
 ;;^UTILITY(U,$J,358.3,7591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7591,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,7591,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,7591,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,7592,0)
 ;;=C78.00^^42^498^137
 ;;^UTILITY(U,$J,358.3,7592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7592,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,7592,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,7592,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,7593,0)
 ;;=D57.1^^42^498^178
 ;;^UTILITY(U,$J,358.3,7593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7593,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
